Literature DB >> 876702

Human beta-glucuronidase. II. Fate of infused human placental beta-glucuronidase in the rat.

D Achord, F Brot, A Gonzalez-Noriega, W Sly, P Stahl.   

Abstract

Human placental beta-glucuronidase could be identified in rat organs by heating organ extracts to 65 degrees which selectively inactivated endogenous rat enzyme. Infused enzyme was rapidly cleared from rat plasma (t0.5 of 3.5 min). From 50-60% of the infused dose was accounted for in rat liver and spleen 24 hr after infusion. Removal of abdominal viscera, including the spleen, and interruption of the portal circulation before infusion slowed the plasma disappearance (t0.5 of 60 min) and allowed significant uptake by bone and other organs. Subcellular fractionation of liver 18 hr postinfusion localized the human enzyme in the mitochondrial-lysosomal fraction. The half-disappearance times of infused human enzyme were 2.6 days in rat liver and 5.8 days in rat spleen. Periodate treatment of human placental beta-glucuronidase destroyed 90% of its binding to concanavalin A-Sephadex rose, reduced its heat stability, and abolished its rapid clearance from rat plasma after infusion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 876702     DOI: 10.1203/00006450-197707000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  20 in total

1.  Recognition of human urine alpha-N-acetylglucosaminidase by rat hepatocytes. Involvement of receptors specific for galactose, mannose 6-phosphate and mannose.

Authors:  K Ullrich; R Basner; V Gieselmann; K Von Figura
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

Review 2.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

3.  Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages.

Authors:  P D Stahl; J S Rodman; M J Miller; P H Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene.

Authors:  J W Kyle; E H Birkenmeier; B Gwynn; C Vogler; P C Hoppe; J W Hoffmann; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Cloning, sequencing, and expression of cDNA for human beta-glucuronidase.

Authors:  A Oshima; J W Kyle; R D Miller; J W Hoffmann; P P Powell; J H Grubb; W S Sly; M Tropak; K S Guise; R A Gravel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII.

Authors:  Ha T Huynh; Jeffrey H Grubb; Carole Vogler; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

Review 7.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

8.  Receptor-mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro.

Authors:  E J Campbell; R R White; R M Senior; R J Rodriguez; C Kuhn
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

9.  Enzyme replacement therapy for murine mucopolysaccharidosis type VII.

Authors:  M S Sands; C Vogler; J W Kyle; J H Grubb; B Levy; N Galvin; W S Sly; E H Birkenmeier
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Modulation of a glycoprotein recognition system on rat hepatic endothelial cells by glucose and diabetes mellitus.

Authors:  J A Summerfield; J Vergalla; E A Jones
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.